This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

       

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Unit for Hours:H

Unit for Minutes: M

Loading text: $loading

Filter redirection page URL: /en-ie/events/

Login overlay needed?:

Filter Tags:All Medical indications|All Products|All Therapy Area

Filter Tags values when filtered by all Tags:All Medical indications|All Products|All Therapy Area

OutofBox filter category name:Format

Filter Reset all button text:Reset All

Filter Apply button text:Apply

Events registration success message: Registration successful

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successful

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Show More Naivagation Values: 10|25|50

Previous Text label: Previous

Next Text label: Next

Show Text label: Show:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:Not provided

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/Ireland/MP4/Webinar/zejula-gyncancerxchange-esgo-meet-recorded-video.mp4

Webinar | English | 19:21

Zejula GyncancerXchange ESGO Meet the Experts Post-Program

In this Video, Professor Jonathan A. Ledermann will discuss clinical considerations for selection of PARPi therapy for women with advanced ovarian cancer, the importance of an integrated patient care approach and patient considerations for dosing, administration and optimising adherence to therapy.

POM. Further information available from GlaxoSmithKline, 12 Riverwalk, Citywest, Business Campus, Dublin 24. Tel: 01-4955000

Zejula prescribing information and adverse event reporting information

For additional Video/Journal Article Resources available Click Here

Speaker

Professor Jonathon A. Ledermann, MD, FMedSci

Professor Jonathon A. Ledermann, MD, FMedSci

Consultant Medical Oncologist, Clinical Director, UCL Cancer Institute and UCL Hospital London, United Kingdom